genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Biomarkers
Looking Beyond NIPT, Natera Eyes Cancer, Transplant Testing Growth
Drug Discovery
Horizon Therapeutics Sets Sights on Blockbuster Sales, Broader Pipeline
Coronavirus
Synthetic Data for a Real Pandemic
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
News
Bone disorders
Bone Remodeling Technique Could Lead to New Osteoporosis Therapies
Bioprocessing
Evotec Subsidiary Expands mAb Contract with the U.S. DOD
Bioprocessing
Essent Biologics Launches to Service Regenerative Medicine Markets
Coronavirus
Eli Lilly, Regeneron Report Positive Phase III COVID-19 Antibody Results
Drug Discovery
Potential Vaccine against Deadly Bacterial Disease
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
New Vaccines Face Cold-Chain Manufacturing Challenges
Bioprocessing
Speeding Up Peptide Mapping
Bioprocessing
Biopharma Needs “Digital Maturity” and the Right Motivation for Bioprocess 4.0
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
Evotec Subsidiary Expands mAb Contract with the U.S. DOD
Bioprocessing
Essent Biologics Launches to Service Regenerative Medicine Markets
Coronavirus
Eli Lilly, Regeneron Report Positive Phase III COVID-19 Antibody Results
Drug Discovery
Potential Vaccine against Deadly Bacterial Disease
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Prostate Cancer
Prostate Cancer
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Prostate Cancer
Prostate Cancer Inhibited by Compound against “Undruggable” Target
Prostate Cancer
Cancer Screen with Spheroids Shows Promise Therapeutically
Prostate Cancer
New Prostate Cancer Subtype Identified, Responsive to Immunotherapy
Prostate Cancer
Dendreon Finds a “Stalking Horse” in Valeant
Prostate Cancer
Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy
Prostate Cancer
FIRST USE OF NANOSENSORS TO MEASURE CANCER BIOMARKERS IN BLOOD
Prostate Cancer
An Aspirin a Day Keeps the Breast Cancer Away
Prostate Cancer
Dendreon Gets Green Light in Europe
Prostate Cancer
3D Bioscaffold Mimics Antigen-Presenting Cells for Improved T-Cell Expansion
Prostate Cancer
Scientists Pinpoint New Target for Prostate Cancer
Prostate Cancer
Prostate Cancer Aggressiveness May Be Assessed by Probing the Metabolome
Prostate Cancer
Prostate Cancer Risk Potentially Decreased by Following the Mediterranean Diet
Prostate Cancer
Takeda Halts Development of Prostate Cancer Drug Orteronel
Prostate Cancer
Metastatic Prostate Cancer Target Identified for Combo Therapy
Prostate Cancer
Prostate Cancer Researchers Find New Target in Battle against Resistance
1
2
3
...
7
Page 1 of 7
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![The researchers used a technique called confocal microscopy to confirm that the cell lines were forming spheres. Here is the BxPC-3-KRASWT cell line. [Kota et al./The Scripps Research Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/May14_2018_TheScrippsResearchInst_BxPC3KRASWTCellLine8851901611-265x198.jpg "Cancer Screen with Spheroids Shows Promise Therapeutically")
![Depiction of the molecular processes involved in a new subtype of metastatic prostate cancer characterized by loss of the gene CDK12. [Alexander Tokarev/Ella Maru Studio]](https://www.genengnews.com/wp-content/uploads/2018/08/Jun14_2018__AlexanderTokarev_CDK121791251469-265x198.jpg "New Prostate Cancer Subtype Identified, Responsive to Immunotherapy")
![Treated prostate cancer cells. [Mateus Crespo/Professor Johann de Bono/ICR]](https://www.genengnews.com/wp-content/uploads/2018/08/Jun28_2018_ProfJohannDeBonoICR_TreatedProstateCancerCells1561322408-265x198.jpg "Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy")